AbbVie Inc vs AMGEN Inc

AbbVie Inc operates in Healthcare and AMGEN Inc in Unknown sector. This is not a choice between rivals but a question of exposure — the two respond to different forces and can move in opposite directions on the same day.

This page puts both sets of numbers side by side. It does not declare a winner — VAQO is not an investment adviser — it arranges what you need to compare, instead of leaving you to open two pages and hold figures in your head.

Healthcare · Drug Manufacturers
$250.95
+0.87%
Day range: $246.83 – $251.17
Volume: 3.9M
Unknown · Stock
$391.27
-0.48%
Day range: $389.28 – $395.55
Volume: 2.9M

What the numbers show

In the latest session AbbVie Inc (ABBV) led with 0.87% against -0.48% for AMGEN Inc (AMGN) — a gap of 1.35 percentage points.

ABBV vs AMGN — frequently asked questions

How much do AbbVie Inc and AMGEN Inc cost today?

AbbVie Inc (ABBV) trades at $250.95 (+0.87%) and AMGEN Inc (AMGN) at $391.27 (-0.48%) in the latest session.

What is the difference between AbbVie Inc and AMGEN Inc?

AbbVie Inc (ABBV) operates in Healthcare and AMGEN Inc (AMGN) in Unknown sector, so they respond to different forces and can move in opposite directions.

ABBV or AMGN — which is better?

VAQO makes no recommendations and is not an investment adviser. What it provides is both sets of numbers side by side — price, daily move, volatility and risk scoring from a model whose accuracy is published openly — so the decision rests on a comparison rather than a feeling.

This is not financial advice.

← All comparisons

Last updated: 2026-09-10